Tag: Sava Technologies
In brief: CGM transformation, MK Battery acquisition, Sava-Ascensia partnership
October 16, 2026HME News Staff
AURORA, Colo. – Continuous glucose monitors (CGMs) could transform disease management for millions of Americans with Type 2 diabetes who don't take insulin, according to new research published in the New England Journal of Medicine.
The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common...
Sava receives $36M in funding, partners with Ascensia
October 14, 2026HME News Staff
LONDON – Sava Technologies has received $36 million in Series B funding, alongside an agreement appointing Ascensia, a subsidiary of PHC Holdings Corp., as its commercialization and distribution partner, starting off in Europe. Founded in 2019, Sava has developed a wearable built on its proprietary microsensor technology that measures molecules just beneath the skin, painlessly and continuously. While starting with glucose, the platform is designed to track other biomarkers, too, opening the...